Finding cures for tropical diseases: Is open source an answer?

被引：51

作者：

Maurer, SM ^{[1
]}

Rai, A

Sali, A

机构：

[1] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA

[2] Duke Univ, Sch Law, Durham, NC 27706 USA

[3] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA

[4] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA

[5] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA

来源：

PLOS MEDICINE | 2004年 / 1卷 / 03期

关键词：

D O I：

10.1371/journal.pmed.0010056

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：183 / 186

页数：4

共 14 条

[1] Developing and distributing essential medicines to poor countries: The DEFEND proposal [J].

Ganslandt, M ;

Maskus, KE ;

Wong, EV .

WORLD ECONOMY, 2001, 24 (06) :779-795

[2]

HAMILTON D, 2003, MRNA CAP 1

[3]

KREMER M, 2001, INNOVATION POLICY EC, P73

[4] Some simple economics of open source [J].

Lerner, J ;

Tirole, J .

JOURNAL OF INDUSTRIAL ECONOMICS, 2002, 50 (02) :197-234

[5]

*NATL I HLTH CAR M, 2002, CHANG PATT PHARM INN

[6]

Normile D, 2002, SCIENCE, V296, P1785

[7] Virtual drug discovery and development for neglected diseases through public-private partnerships [J].

Nwaka, S ;

Ridley, RG .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (11) :919-928

[8]

PECOUL B, 2004, DEV DRUGS NEGLECTED, V1, pE6

[9]

RAI AK, 2005, INNOVATION FRONTIER

[10]

RELMAN A, 2002, AM DRUG PROBLEM, P27

← 1 2 →